Compare Kabelindo Murni Tbk (KBLM) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kabelindo Murni Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Kabelindo Murni Tbk trades at Rp352 (market cap 394.24B, 540.5K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Kabelindo Murni Tbk is far larger — about 3.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KBLM | SCPI | |
|---|---|---|
Market Cap | 394.24B | 104.4B |
Volume | 540.5K | — |
Lot | 5.41K | — |
Turnover | 189.11M | — |
Average Price | 349.88 | — |
Value | 189.11M | — |
Indicative Equilibrium Price | 352 | — |
Indicative Equilibrium Volume | 11 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kabelindo Murni Tbk
PT Kabelindo Murni Tbk (the Company) was established based on Notarial Deed No. 71 dated October 11, 1979 of Fredrik Alexander Tumbuan, S.H. PT Kabelindo Murni Tbk manufactures cable and cable fittings using raw materials such as polyethylene and heat shrinkable materials tubes. Installed production capacity has reached 26,000 tons of power cables and 1,330,000 Km pair of telephone cables.
Read more on KBLM →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
